Olema Pharmaceuticals, Inc. SEC filings OLMA
Olema Pharmaceuticals, Inc. has 562 filings in SEC EDGAR's recent list, going back to Aug 27, 2018. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 15, 2025 | — |
| EFFECT | Filing | Jan 15, 2025 | — |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| CORRESP | Letter to the SEC | Jan 13, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 8, 2025 | — |
| D | Filing | Dec 12, 2024 | — |
| EFFECT | Filing | Feb 9, 2024 | — |
| CORRESP | Letter to the SEC | Feb 7, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 7, 2024 | — |
| D | Filing | Sep 14, 2023 | — |
| EFFECT | Filing | May 2, 2022 | — |
| CORRESP | Letter to the SEC | Apr 28, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2022 | — |
| DEL AM | Filing | Mar 3, 2022 | — |
| EFFECT | Filing | Nov 18, 2020 | — |
| CERT | Filing | Nov 18, 2020 | — |
| SEC STAFF LETTER | Filing | Nov 17, 2020 | — |
| 8-A12B | Filing | Nov 17, 2020 | — |
| CORRESP | Letter to the SEC | Nov 16, 2020 | — |
| CORRESP | Letter to the SEC | Nov 16, 2020 | — |
| CORRESP | Letter to the SEC | Nov 16, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2020 | — |
| DRSLTR | Filing | Oct 23, 2020 | — |
| DRS/A | Filing | Oct 23, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 16, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 13, 2020 | — |
| D | Filing | Oct 13, 2020 | — |
| DRS | Filing | Sep 21, 2020 | — |
| DRSLTR | Filing | Sep 18, 2020 | — |
| D/A | Filing | Jun 23, 2020 | — |
| D | Filing | Mar 27, 2020 | — |
| D | Filing | Aug 27, 2018 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OLMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1750284
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.